LGNDCongressional Stock Trades
Ligand Pharmaceuticals Inc.
Pharmaceutical Preparations
Congressional stock trades in Ligand Pharmaceuticals Inc. (LGND) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
2
Politicians Trading
1
Last Traded
Jan 15, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr.D | Feb 13, 2026 | Jan 15, 2026 | Buy | $1,001 - $15,000 | +44.58% |
| Gilbert Ray Cisneros, Jr.D | Feb 13, 2026 | Jan 5, 2026 | Buy | $1,001 - $15,000 | +47.63% |
Price History
About Ligand Pharmaceuticals Inc.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.